Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways
about
ALK Signaling and Target Therapy in Anaplastic Large Cell LymphomaBardet-Biedl syndrome proteins 1 and 3 regulate the ciliary trafficking of polycystic kidney disease 1 proteinTargeting the tumor microenvironment: JAK-STAT3 signalingRegulation of STATs by polycystin-1 and their role in polycystic kidney diseaseExperimental therapies and ongoing clinical trials to slow down progression of ADPKDScreening approaches to generating STAT inhibitors: Allowing the hits to identify the targetsGenetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation.IL-6/STAT3 promotes regeneration of airway ciliated cells from basal stem cells.Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney DiseaseVasopressin and disruption of calcium signalling in polycystic kidney disease.Emerging role of autophagy in kidney function, diseases and agingSTAT3 Signaling in Polycystic Kidney DiseaseFour clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screeningThe STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 MutationsCutaneous plasmablastic lymphoma in an immunocompetent patient with long-term pyrimethamine use for essential thrombocythemia: a case report and literature review.Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer.Primary cilia and kidney injury: current research status and future perspectivesAutocrine IL-10 activation of the STAT3 pathway is required for pathological macrophage differentiation in polycystic kidney diseasePolycystic kidney disease in 2011: Connecting the dots toward a polycystic kidney disease therapy.Cancer stem cells, microRNAs, and therapeutic strategies including natural products.New treatments for autosomal dominant polycystic kidney diseaseSTAT signaling in the pathogenesis and treatment of myeloid malignancies.Strategies targeting cAMP signaling in the treatment of polycystic kidney disease.Genetic Interactions of STAT3 and Anticancer Drug Development.JAK inhibition and progressive kidney disease.STAT3-Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer Therapy.The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations.The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1.Sclt1 deficiency causes cystic kidney by activating ERK and STAT3 signaling.Autophagy and Tubular Cell Death in the Kidney.Combination drug versus monotherapy for the treatment of autosomal dominant polycystic kidney disease.Primary Cilia in Cystic Kidney Disease.Src family kinases in chronic kidney disease.Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.Extracellular Signal-Regulated Kinase 1/2 Regulates Mouse Kidney Injury Molecule-1 Expression Physiologically and Following Ischemic and Septic Renal Injury.Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors.The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer.Identification of Targets of Interleukin-13 and Signal Transducer and Activator of Transcription-6 (STAT6) Signaling in Polycystic Kidney Disease.The STAT3 Target Gene TNFRSF1A Modulates the NF-κB Pathway in Breast Cancer Cells.
P2860
Q21129306-1918BD65-54A3-4A2D-9440-27A2E5EEBCA7Q24299480-411C831C-D934-463F-8948-2B9E76B854B9Q26825658-AB9F4C71-0928-4D1A-BEC7-13A3A02AB545Q26852136-985C18AC-98A4-42A0-9F60-50FFDDDE602AQ27001230-213A6C61-4038-47C7-9191-644013550EC8Q27024482-596F9A16-3E4C-4548-8582-ED78EC644946Q33872509-0CC0A3E5-32B6-4D7C-BEE2-51205E35D8EEQ33974670-85330F13-8C26-4543-8393-D02586F1BA39Q34144162-C2D4D74C-D958-4419-B3EC-5D50333B9D38Q35658562-665B8EE8-1FEE-4E67-A1F0-E6527E6369E8Q35962991-64941DBC-7102-4B60-A1B2-4C9B266F03AAQ36194753-FCCCA5F1-93E5-44FC-8C05-3129FA064340Q36218762-2B8CDF58-6CF4-4DAF-A48A-29841B92F411Q36384043-767B688C-775B-4C0E-BAFD-F6098666A8FAQ36481950-21611FD6-44F7-4F43-8C34-AC4A729AB5CFQ36634501-8E2D12D2-7D20-4ADC-A3CB-DB2E97EDF0F8Q37068166-8925A95D-E72C-4881-ADE0-DF0B9A26D5CAQ37234721-73D29BBB-F69D-4908-BE46-3779C2BDA261Q37305901-EEB3AC63-9F0B-47B7-8C37-B7D37269ACE8Q37967082-91B36DAE-AD58-450C-9E9D-4328FBBA0981Q38023238-20AC4131-A5B6-49B6-BF09-D4DCFFFEBF69Q38099698-85ECAF78-2323-417A-AFEC-0814D2B6188BQ38140880-92021C93-752B-4519-BF1B-A4F6190C6800Q38171193-E0811544-C977-49D5-85CD-57480B54A93EQ38198930-C53B5FC8-DBBD-4049-9B92-AC0379A1FF25Q38270332-3F875A80-D2F5-490C-AC2C-745776CCB8E5Q38667977-0A32A19B-3B1D-45D3-8C94-3AB64D450843Q38687571-4F71AFFE-454C-4F9D-BB14-3E96888DD58DQ38785659-7957141C-A41E-4640-8CFF-64AA91DAE29BQ38795694-98CE0577-234F-44D1-9044-BF1762ACFC42Q38875284-1419663A-4A88-492C-852C-1EF73FFC5ECBQ38960067-C5F36BDD-C5A7-4515-9D57-3E76D0FD4032Q39242476-D521FF40-D2DE-436D-87C8-3BB6418CDAFDQ40159797-3C69E10C-4616-4F85-9633-AE4971A88295Q41661686-333148C6-32F1-400C-992C-E90D06C9F13AQ46273808-26DC0C78-A6E8-41FF-8CED-8F2AEB21D9A2Q47337796-4C8CDC97-4628-411C-97DB-5B94CAA3D96CQ48123892-725F01A7-119A-4F09-AC20-D80DE70C5B5BQ50420556-94C76A0F-8304-47BB-B5AE-A763E08AE9D6Q55278638-96B04EF1-7863-4FEC-BAA1-09CE492875D7
P2860
Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pyrimethamine inhibits adult p ...... lating STAT signaling pathways
@ast
Pyrimethamine inhibits adult p ...... lating STAT signaling pathways
@en
type
label
Pyrimethamine inhibits adult p ...... lating STAT signaling pathways
@ast
Pyrimethamine inhibits adult p ...... lating STAT signaling pathways
@en
prefLabel
Pyrimethamine inhibits adult p ...... lating STAT signaling pathways
@ast
Pyrimethamine inhibits adult p ...... lating STAT signaling pathways
@en
P2093
P2860
P356
P1476
Pyrimethamine inhibits adult p ...... lating STAT signaling pathways
@en
P2093
Ayumi Takakura
Benjamin D Humphreys
David A Frank
Erik A Nelson
Kambiz Zandi-Nejad
Nadeem Haque
P2860
P304
P356
10.1093/HMG/DDR338
P577
2011-08-05T00:00:00Z